Retraction: Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy (Neurology (2001) 57 (445-449) DOI: 10.1212/wnl.57.3.445);Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

Neurology

Volumn 57, Issue 3, 2001, Pages 445-449

  Sato, Yoshihiro ^a,b   Kondo, I ^b   Ishida, S ^a   Motooka, H ^a   Takayama, K ^a   Tomita, Y ^a   Maeda, H ^a   Satoh, K ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MALE; MONOTHERAPY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0035859862     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000009359     Document Type: Erratum

References (28)

1. Osteopathien bei antiepileptischer dauerbehandlung
2. Osteopathien bei antiepileptischer langzeittherapie (vorläufige mitteilung)
3. Anticonvulsant drugs: An update
4. Die osteopathia antiepileptica bei jungendlichen und erwachsenen
5. Effect of antiepileptic drug therapy and exposure to sunlight on vitamin D status in institutionalized patients
6. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in patients with epilepsy
7. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants
8. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
9. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: A randomized comparative monotherapy trial
10. Randomized comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy
11. Effect of carbamazepine and valproate on bone mineral density
12. Effect of valproate on bone mineral density
13. Evaluation of bone mineral density in children receiving antiepileptic drugs
14. Valproate therapy: Predisposition to bone fracture?
15. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years
16. Metacarpal bone mass in normal and osteoporotic Japanese women using computed x-ray densitometry
17. The diagnosis of osteoporosis
18. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
19. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
20. The second metacarpal bone density by microdensitometry method
21. A prospective study to evaluate the dose of vitamin D required to correct 25-hydroxyvitamin D levels, calcium and alkaline phosphatase inpatients at risk of developing antiepileptic drug-induced osteomalacia
22. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid
23. Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients
24. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
25. Long-term anticonvulsant therapy leads to low bone mineral density: Evidence for direct drug effect of phenytoin and carbamazepine on human osteoblast-like cells
26. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
27. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures
28. Long-and short-term side effects and safety of calcitonin in man: A prospective study